Pacira BioSciences
PCRX
PCRX
258 hedge funds and large institutions have $1.88B invested in Pacira BioSciences in 2023 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 95 increasing their positions, 94 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less capital invested
Capital invested by funds: $1.89B → $1.88B (-$9.79M)
3% less funds holding
Funds holding: 266 → 258 (-8)
13% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 40
Holders
258
Holding in Top 10
4
Calls
$8.6M
Puts
$7.33M
Top Buyers
| 1 | +$31.5M | |
| 2 | +$24.6M | |
| 3 | +$19.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$13.4M |
Top Sellers
| 1 | -$63.3M | |
| 2 | -$33.9M | |
| 3 | -$20.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.2M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$9.31M |